SK-N-AS Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The SK-N-AS cell line is derived from a neuroblastoma of a human child and is extensively used in neuro-oncology research. Neuroblastoma is a type of cancer that arises from neural crest cells and predominantly affects children. SK-N-AS cells provide a valuable model for studying the biology and treatment of neuroblastoma, particularly in understanding the molecular mechanisms driving tumor development and progression. This cell line is characterized by its relatively undifferentiated state, which makes it useful for examining the pathways involved in neuronal differentiation and malignancy. SK-N-AS cells exhibit an adherent growth pattern and possess a neuroblastic morphology. They express various markers associated with neural crest cells and neuroblastoma, including neuron-specific enolase (NSE) and chromogranin A. Researchers utilize SK-N-AS cells to investigate the genetic and epigenetic changes associated with neuroblastoma, such as MYCN amplification and ALK mutations. These cells are also employed in high-throughput drug screening and preclinical testing of novel chemotherapeutic agents and targeted therapies. Additionally, SK-N-AS cells are used to study the mechanisms of resistance to conventional therapies and to develop strategies to overcome such resistance. The relevance of SK-N-AS cells in neuroblastoma research underscores their importance in advancing our understanding of this aggressive childhood cancer and in improving therapeutic approaches for affected patients. |
|---|---|
| Organism | Human |
| Tissue | Brain |
| Disease | Neuroblastoma |
| Metastatic site | Bone marrow |
| Synonyms | SKN-AS, SKNAS |
Characteristics
| Age | 6 years |
|---|---|
| Gender | Female |
| Ethnicity | European |
| Morphology | Epithelial |
| Cell type | Neuroblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | SK-N-AS (Cytion catalog number 305272) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1700 |
Biomolecular Data
| Tumorigenic | Yes, in nude mice |
|---|---|
| Mutational profile | Mutation: NRAS, p.Gln61Lys (c.181C>A), heterozygous |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS, 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use 50% basal medium + 40% FBS + 10% DMSO, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305272-270824 | Certificate of Analysis | 23. May. 2025 | 305272 |
| 305272-250924 | Certificate of Analysis | 23. May. 2025 | 305272 |
-
Related products
Related products
SK-BR-3 CellsOrganism Human Tissue Breast, mammary gland Disease Invasive ductal carcinoma CAD$545.10*